Zimmer Biomet Executive Files SEC Ownership Disclosure
Brian Hatcher's Form 3 reveals stock options, RSUs, and direct share holdings at Zimmer Biomet.
Zimmer Biomet Holdings executive Brian Hatcher disclosed his initial beneficial ownership stake to the Securities and Exchange Commission, filing a Form 3 that details a range of equity holdings in the orthopedic device maker. The filing marks Hatcher's first public record of ownership since joining or assuming a reportable role at the company.
Hatcher directly owns 5,988 common shares of Zimmer Biomet, according to the SEC disclosure. His holdings also include restricted stock units and two notable tranches of employee stock options — 7,035 options carrying an exercise price of $117.22 that expire in 2032, and a smaller block of 2,156 options priced at $120.04 set to expire in 2029.
Read more PPL Corporation Holds 2026 EPS Guidance Despite Q2 Miss →
Form 3 filings are required by the SEC whenever a corporate insider — such as a director, officer, or significant shareholder — first becomes subject to reporting obligations. They offer investors a baseline snapshot of an insider's equity position before any subsequent purchases or sales are logged on Form 4.
The options Hatcher holds are underwater or near the market price depending on where ZBH shares trade, making their eventual exercise tied closely to the company's stock performance over the coming years. The spread between the two exercise prices and expiration dates suggests the grants were awarded at different points during his tenure or under separate compensation plans.
Continue reading at Stock Titan.
